Abstract

Logopenic progressive aphasia is a neurodegenerative syndrome characterized by sentence repetition and naming difficulties arising from left-lateralized temporoparietal atrophy. Clinical descriptions of logopenic progressive aphasia largely concentrate on profiling language deficits, however, accumulating evidence points to the presence of cognitive deficits even on tasks with minimal language demands. Although non-linguistic cognitive deficits in logopenic progressive aphasia are thought to scale with disease severity, patients at discrete stages of language dysfunction display overlapping cognitive profiles, suggesting individual-level variation in cognitive performance, independent of primary language dysfunction. To address this issue, we used principal component analysis to decompose the individual-level variation in cognitive performance in 43 well-characterized logopenic progressive aphasia patients who underwent multi-domain neuropsychological assessments and structural neuroimaging. The principal component analysis solution revealed the presence of two, statistically independent factors, providing stable and clinically intuitive explanations for the majority of variance in cognitive performance in the syndrome. Factor 1 reflected ‘speech production and verbal memory’ deficits which typify logopenic progressive aphasia. Systematic variations were also confirmed on a second, orthogonal factor mainly comprising visuospatial and executive processes. Adopting a case-comparison approach, we further demonstrate that pairs of patients with comparable Factor 1 scores, regardless of their severity, diverge considerably on visuo-executive test performance, underscoring the inter-individual variability in cognitive profiles in comparably ‘logopenic’ patients. Whole-brain voxel-based morphometry analyses revealed that speech production and verbal memory factor scores correlated with left middle frontal gyrus, while visuospatial and executive factor scores were associated with grey matter intensity of right-lateralized temporoparietal, middle frontal regions and their underlying white matter connectivity. Importantly, logopenic progressive aphasia patients with poorer visuospatial and executive factor scores demonstrated greater right-lateralized temporoparietal and frontal atrophy. Our findings demonstrate the inherent variation in cognitive performance at an individual- and group-level in logopenic progressive aphasia, suggesting the presence of a genuine co-occurring cognitive impairment that is statistically independent of language function and disease severity.

Highlights

  • Logopenic progressive aphasia (LPA) is a rare neurodegenerative brain disorder, the canonical features of which centre on language dysfunction, including slowing in spontaneous speech, phonological errors and paraphasias, sentence repetition, sentence comprehension and wordfinding difficulties (Gorno-Tempini et al, 2008; GornoTempini et al, 2011; Leyton et al, 2014)

  • LPA patients performed significantly worse than controls on measures of global cognition, as well as targeted neuropsychological assessments of episodic memory, semantic naming and comprehension, single-word repetition, visuo-constructional abilities and executive function

  • This study demonstrates that the presence of visuospatial and executive deficits in LPA, beyond core language disturbance, does not reflect advancing disease severity

Read more

Summary

Introduction

Logopenic progressive aphasia (LPA) is a rare neurodegenerative brain disorder, the canonical features of which centre on language dysfunction, including slowing in spontaneous speech, phonological errors and paraphasias, sentence repetition, sentence comprehension and wordfinding difficulties (Gorno-Tempini et al, 2008; GornoTempini et al, 2011; Leyton et al, 2014). The locus of atrophy in early stages of LPA is predominantly leftlateralized and centred on the left inferior parietal lobule, lateral temporal and perisylvian cortical regions surrounding the left superior/middle/inferior temporal gyrus (Gorno-Tempini et al, 2008; Rohrer et al, 2010; Leyton et al, 2012; Teichmann et al, 2013; Krishnan et al, 2016). The majority of LPA patients (>90%) present with abnormal levels of cortical b-amyloid, characteristic of Alzheimer’s disease (Rabinovici et al, 2008; Leyton et al, 2011; Chare et al, 2014; Santos-Santos et al, 2018), recent histopathological and biomarker evidence points to the presence of nonAlzheimer pathologies in a minority of clinically diagnosed LPA patients (Mesulam et al, 2014; Bergeron et al, 2018)

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call